Adult acute lymphoblastic leukemia (ALL) is a type of cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell). Adult acute lymphoblastic leukemia (ALL; also called acute lymphocytic leukemia) is a cancer of the blood and bone marrow. This type of cancer usually gets worse quickly if it is not treated. Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature lymphocytes. Symptoms may include feeling tired, pale skin color, fever, easy bleeding or bruising, enlarged lymph nodes, or bone pain.Symptoms: Feeling tired, pale color, fever, easy bleeding .
B-cell acute lymphoblastic leukemia is a cancer that affects your "B lymphocytes" -- white blood cells that grow in the soft center of your bones, called marrow. B lymphocytes are supposed to grow Author: Mary Jo Dilonardo. Acute lymphocytic (or lymphoblastic) leukemia is sometimes called ALL. It starts in the bone marrow where blood cells are made. It is more common in children than in adults. Learn about the risk factors for acute lymphocytic leukemia and if there are things you might be able to do to help lower your.
Adult acute lymphoblastic leukemia (ALL) treatment options include chemotherapy, radiation therapy, stem cell transplant, and targeted therapy. Get detailed information about the molecular genetics, prognosis, and treatment of ALL in this summary for clinicians. Nov 07, 2018 · Acute lymphocytic leukemia is the most common childhood cancer, although it can develop in adults, too. Learn about the acute lymphocytic leukemia survival rate here. Discover the factors that can Author: Rachel Nall, RN, BSN, CCRN.
Oct 17, 2018 · (Note: This information is about treating acute lymphocytic leukemia (ALL) in adults. To learn about ALL in children, see Leukemia in Children.) The main treatment for acute lymphocytic leukemia (ALL) in adults is typically long-term chemotherapy (chemo). In recent years, doctors have begun to use more intensive chemo regimens, which has led to more responses to treatment.Last Revised: October 17, 2018.